LBO France

Public data, unclaimed profile

Fund manager (General Partner). Assets under management: ≈ USD 2.7bn.

At a glance

Based on observed investment behaviour: 1 recorded deal

Investor type: Private equity or venture capital fund (inferred, not verified)
Capital type: Private equity (inferred from profile)
Observed ticket: Data unavailable; Stated ticket : 10 M$ – 100 M$
Countries: Data unavailable
Activities: Pharmacy and drug distribution (1)
Instruments: Equity (1)
Stages: Growth (1)
Recent activity: 0 deal in 12 months, latest Sept 2017

Stated thesis versus observed behaviour

Fewer than three recorded deals: insufficient evidence to compare thesis and behaviour.

Does this fund fit your project?

Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.

Find my matches

Investment thesis

Criteria published by the fund, recorded and checked by Invest Matching.

Investment ticket: 10 M$ – 100 M$
Instruments: Equity
Preferred sectors: Manufacturing, Healthcare, Business & personal services, Retail & distribution, Media & entertainment*, Tourism & hospitality*
Target geographies: France
Stages (stated by the fund and from its deals): Growth
Website: https://www.lbofrance.com/

Reference deals

Recent public deals: they say better than a thesis what the fund actually signs.

Joliba Fund I

September 2023 · Côte d'Ivoire

Undisclosed amountFund of fundsCo-Invest

Fund-of-funds commitment: subscription in Joliba Capital

Co-investor alongside IFC (International Finance Corporation)

Activity : Fonds d'investissement

Instrument : Souscription pouvant atteindre 15 M EUR (7,5 M EUR du programme SME Ventures, 7,5 M EUR du guichet IDA) · Vehicle : Joliba Fund I

Joliba Fund I is a private equity fund targeting SMEs in Francophone West and Central Africa. It invests in consumer goods and services, financial services, transport and logistics, agribusiness, business services, healthcare and education.

Why they invested

Financing SMEs in Francophone West and Central Africa
Targeting markets underserved by private equity
Supporting consumer, financial, logistics, agribusiness and healthcare sectors
Significant focus on IDA-eligible countries

Co-investors FMO, Proparco

Source : ifc.orgN1 · Primary source

PIEX

September 2017

GrowthUndisclosed amountEquityHealthcareCo-Invest

Co-investor alongside Trocadero Capital Partners

Activity : Pharmacy and drug distribution

Instrument : prise de participation majoritaire

PIEX distributes pharmaceutical and parapharmaceutical products in French-speaking Sub-Saharan Africa.

Why they invested

Develop a specialist distributor in Francophone Sub-Saharan Africa
Support a growth transaction with LBO France and AfricInvest
Strengthen the pharmaceutical distribution platform

Co-investors AfricInvest, BNP Paribas Développement, Bpifrance (Fonds Averroès / Afrique)

Source : africaglobalfunds.com

In short

LBO France invests tickets ranging from 10 M$ to 100 M$, across the following sectors: Manufacturing, Healthcare, Business & personal services, Retail & distribution, Media & entertainment, and Tourism & hospitality, in the following areas: France. Check in 30 seconds whether your company fits these criteria.

Check my eligibility for this fund Do you represent this fund? Claim this profile